Կլոնիդին (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Կլոնիդին" in Armenian language version.

refsWebsite

Global rank Armenian rank

46nih.gov

4^th place

3^rd place

36doi.org

2^nd place

4^th place

14semanticscholar.org

11^th place

428^th place

4archive.org

6^th place

4worldcat.org

5^th place

10^th place

2drugs.com

399^th place

102^nd place

2clincalc.com

3,912^th place

1,857^th place

1books.google.com

3^rd place

17^th place

1cpnp.org

low place

1anesthesia-analgesia.org

low place

1medscape.org

low place

7,341^st place

1aafp.org

1,916^th place

203^rd place

1webmd.com

1,169^th place

367^th place

aafp.org

Blount, BW; Pelletier, AL (2002). «Rosacea: A Common, Yet Commonly Overlooked, Condition». American Family Physician. 66 (3): 435–441. PMID 12182520.

anesthesia-analgesia.org

Fazi, L; Jantzen, EC; Rose, JB; Kurth, CD; Watcha, MF (2001). «A comparison of oral clonidine and oral midazolam as preanesthetic medications in the pediatric tonsillectomy patient» (PDF). Anesthesia and Analgesia. 92 (1): 56–61. doi:10.1097/00000539-200101000-00011. PMID 11133600. S2CID 18885497.

archive.org

Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC (April 2013). «Impact of FDA Advisories on Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder». Psychiatric Services. 64 (4): 339–46. doi:10.1176/appi.ps.201200147. PMC 4023684. PMID 23318985.
Giannini, AJ (1997). Drugs of Abuse (2nd ed.). Los Angeles: Practice Management Information.
Sutherland, SM; Davidson, JR (June 1994). «Pharmacotherapy for post-traumatic stress disorder». The Psychiatric Clinics of North America. 17 (2): 409–23. doi:10.1016/S0193-953X(18)30122-9. PMID 7937367.
Ziegenhorn, AA; Roepke, S; Schommer, NC; Merkl, A; Danker-Hopfe, H; Perschel, FH; Heuser, I; Anghelescu, IG; Lammers, CH (April 2009). «Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial». Journal of Clinical Psychopharmacology. 29 (2): 170–3. doi:10.1097/JCP.0b013e31819a4bae. PMID 19512980. S2CID 31292297.

books.google.com

Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (անգլերեն). John Wiley & Sons. էջ 550. ISBN 9783527607495.

clincalc.com

«The Top 300 of 2019». ClinCalc. Վերցված է 2021 թ․ հոկտեմբերի 16-ին.
«Clonidine - Drug Usage Statistics». ClinCalc. Վերցված է 2021 թ․ հոկտեմբերի 16-ին.

cpnp.org

Freeland, Kathryn; Turner, Amber; Gormley, Lyndsay (2014). «Clonidine and Guanfacine IR vs ER: Old Drugs With "New" Formulations». Mental Health Clinician. 4: 22–26. doi:10.9740/mhc.n186955. Վերցված է 2014 թ․ օգոստոսի 1-ին.

doi.org

Neil, MJ (November 2011). «Clonidine: clinical pharmacology and therapeutic use in pain management». Current Clinical Pharmacology. 6 (4): 280–7. doi:10.2174/157488411798375886. PMID 21827389. S2CID 40756251.
Stähle, Helmut (June 2000). «A historical perspective: development of clonidine». Best Practice & Research Clinical Anaesthesiology. 14 (2): 237–246. doi:10.1053/bean.2000.0079.
Connor DF, Fletcher KE, Swanson JM (December 1999). «A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder». J Am Acad Child Adolesc Psychiatry. 38 (12): 1551–9. doi:10.1097/00004583-199912000-00017. PMID 10596256.
Palumbo, DR; Sallee, FR; Pelham WE, Jr; Bukstein, OG; Daviss, WB; McDermott, MP (February 2008). «Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes». Journal of the American Academy of Child and Adolescent Psychiatry. 47 (2): 180–8. doi:10.1097/chi.0b013e31815d9af7. PMID 18182963.
Daviss, WB; Patel, NC; Robb, AS; McDermott, MP; Bukstein, OG; Pelham WE, Jr; Palumbo, D; Harris, P; Sallee, FR (February 2008). «Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis». Journal of the American Academy of Child and Adolescent Psychiatry. 47 (2): 189–98. doi:10.1097/chi.0b013e31815d9ae4. PMID 18182964.
Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC (April 2013). «Impact of FDA Advisories on Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder». Psychiatric Services. 64 (4): 339–46. doi:10.1176/appi.ps.201200147. PMC 4023684. PMID 23318985.
PALUMBO, DONNA R.; SALLEE, FLOYD R.; PELHAM, WILLIAM E.; BUKSTEIN, OSCAR G.; DAVISS, W. BURLESON; McDERMOTT, MICHAEL P. (February 2008). «Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes». Journal of the American Academy of Child & Adolescent Psychiatry. 47 (2): 180–188. doi:10.1097/chi.0b013e31815d9af7. PMID 18182963.
Kollins, Scott H.; Jain, Rakesh; Brams, Matthew; Segal, Scott; Findling, Robert L.; Wigal, Sharon B.; Khayrallah, Moise (2011 թ․ հունիսի 1). «Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD». Pediatrics (անգլերեն). 127 (6): e1406–e1413. doi:10.1542/peds.2010-1260. ISSN 0031-4005. PMC 3387872. PMID 21555501.
Jäkälä, P.; Riekkinen, M.; Sirviö, J.; Koivisto, E.; Kejonen, K.; Vanhanen, M.; Riekkinen Jr, P. (1999). «Guanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans». Neuropsychopharmacology. 20 (5): 460–470. doi:10.1016/S0893-133X(98)00127-4. PMID 10192826.
Freeland, Kathryn; Turner, Amber; Gormley, Lyndsay (2014). «Clonidine and Guanfacine IR vs ER: Old Drugs With "New" Formulations». Mental Health Clinician. 4: 22–26. doi:10.9740/mhc.n186955. Վերցված է 2014 թ․ օգոստոսի 1-ին.
Nguyen M, Tharani S, Rahmani M, Shapiro M (March 2014). «A review of the use of clonidine as a sleep aid in the child and adolescent population». Clin Pediatr (Phila). 53 (3): 211–6. doi:10.1177/0009922813502123. PMID 24027233. S2CID 742140.
Hoban TF (March 2004). «Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder». Expert Rev Neurother. 4 (2): 307–16. doi:10.1586/14737175.4.2.307. PMID 15853572. S2CID 35000868.
Schachar, Russell; Ickowicz, Abel (1999). «Pharmacological Treatment of Attention-Deficit/HyperactivityDisorder». Handbook of Disruptive Behavior Disorders. Springer US. էջեր 221–254. doi:10.1007/978-1-4615-4881-2_10. ISBN 978-1-4613-7214-1.
Wilens TE, Biederman J, Spencer T (1994). «Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder». J Am Acad Child Adolesc Psychiatry. 33 (3): 424–6. doi:10.1097/00004583-199403000-00018. PMID 8169189.
Fitzgerald, PJ (October 2013). «Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine». Substance Abuse. 7: 171–83. doi:10.4137/SART.S13019. PMC 3798293. PMID 24151426.
Gourlay, SG; Stead, LF; Benowitz, NL (2004). «Clonidine for smoking cessation». The Cochrane Database of Systematic Reviews (3). CD000058. doi:10.1002/14651858.CD000058.pub2. PMC 7038651. PMID 15266422.
Giannini, AJ; Extein, I; Gold, MS; Pottash, ALC; Castellani, S (1983). «Clonidine in mania». Drug Development Research. 3 (1): 101–105. doi:10.1002/ddr.430030112. S2CID 85093127.
Streetz VN, Gildon BL, Thompson DF (April 2016). «Role of Clonidine in Neonatal Abstinence Syndrome: A Systematic Review». Ann Pharmacother. 50 (4): 301–10. doi:10.1177/1060028015626438. PMID 26783353. S2CID 40652097.
Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, Campbell-Yeo M (January 2019). «Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis». JAMA Pediatr. 173 (3): 234–243. doi:10.1001/jamapediatrics.2018.5044. PMC 6439896. PMID 30667476.
Kukoyi A, Coker S, Lewis L, Nierenberg D (January 2013). «Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature». Human & Experimental Toxicology. 32 (1): 107–110. doi:10.1177/0960327112454896. PMID 23111887. S2CID 31570614.
Chang, Eric; Ghosh, Nilasha; Yanni, Daniel; Lee, Sujin; Alexandru, Daniela; Mozaffar, Tahseen (2013). «A Review of Spasticity Treatments: Pharmacological and Interventional Approaches». Critical Reviews in Physical and Rehabilitation Medicine. 25 (1–2): 11–22. doi:10.1615/CritRevPhysRehabilMed.2013007945. ISSN 0896-2960. PMC 4349402. PMID 25750484.
van der Kolk, BA (September–October 1987). «The drug treatment of post-traumatic stress disorder». Journal of Affective Disorders. 13 (2): 203–13. doi:10.1016/0165-0327(87)90024-3. PMID 2960712.
Sutherland, SM; Davidson, JR (June 1994). «Pharmacotherapy for post-traumatic stress disorder». The Psychiatric Clinics of North America. 17 (2): 409–23. doi:10.1016/S0193-953X(18)30122-9. PMID 7937367.
Southwick, SM; Bremner, JD; Rasmusson, A; Morgan CA, 3rd; Arnsten, A; Charney, DS (November 1999). «Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder». Biological Psychiatry. 46 (9): 1192–204. doi:10.1016/S0006-3223(99)00219-X. PMID 10560025. S2CID 32148292.{{cite journal}}: CS1 սպաս․ թվային անուններ: authors list (link)
Strawn, JR; Geracioti, TD, Jr (2008). «Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder». Depression and Anxiety. 25 (3): 260–71. doi:10.1002/da.20292. PMID 17354267. S2CID 33940152.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
Boehnlein, JK; Kinzie, JD (March 2007). «Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin». Journal of Psychiatric Practice. 13 (2): 72–8. doi:10.1097/01.pra.0000265763.79753.c1. PMID 17414682. S2CID 1607064.
Huffman, JC; Stern, TA (2007). «Neuropsychiatric consequences of cardiovascular medications». Dialogues in Clinical Neuroscience. 9 (1): 29–45. doi:10.31887/DCNS.2007.9.1/jchuffman. PMC 3181843. PMID 17506224.
Najjar, F; Weller, RA; Weisbrot, J; Weller, EB (April 2008). «Post-traumatic stress disorder and its treatment in children and adolescents». Current Psychiatry Reports. 10 (2): 104–8. doi:10.1007/s11920-008-0019-0. PMID 18474199. S2CID 23494905.
Ziegenhorn, AA; Roepke, S; Schommer, NC; Merkl, A; Danker-Hopfe, H; Perschel, FH; Heuser, I; Anghelescu, IG; Lammers, CH (April 2009). «Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial». Journal of Clinical Psychopharmacology. 29 (2): 170–3. doi:10.1097/JCP.0b013e31819a4bae. PMID 19512980. S2CID 31292297.
Fazi, L; Jantzen, EC; Rose, JB; Kurth, CD; Watcha, MF (2001). «A comparison of oral clonidine and oral midazolam as preanesthetic medications in the pediatric tonsillectomy patient» (PDF). Anesthesia and Analgesia. 92 (1): 56–61. doi:10.1097/00000539-200101000-00011. PMID 11133600. S2CID 18885497.
Patel, SS; Dunn, CJ; Bryson, HM (1996). «Epidural clonidine: a review of its pharmacology and efficacy in the management of pain during labour and postoperative and intractable pain». CNS Drugs. 6 (6): 474–497. doi:10.2165/00023210-199606060-00007. S2CID 72544106.
Campbell, CM; Kipnes, MS; Stouch, BC; Brady, KL; Kelly, M; Schmidt, WK; Petersen, KL; Rowbotham, MC; Campbell, JN (September 2012). «Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy». Pain. 153 (9): 1815–1823. doi:10.1016/j.pain.2012.04.014. PMC 3413770. PMID 22683276.
Fragkos, Konstantinos C.; Zárate-Lopez, Natalia; Frangos, Christos C. (2016 թ․ հունվարի 25). «What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans». Therapeutic Advances in Gastroenterology (անգլերեն). 9 (3). 1756283X15625586. doi:10.1177/1756283X15625586. ISSN 1756-283X. PMC 4830099. PMID 27134659.
Egolf, A; Coffey, BJ (February 2014). «Current pharmacotherapeutic approaches for the treatment of Tourette syndrome». Drugs of Today. 50 (2): 159–79. doi:10.1358/dot.2014.50.2.2097801. PMID 24619591.
Martinotti, Giovanni; Santacroce, Rita; Pettorruso, Mauro; Montemitro, Chiara; Spano, Maria Chiara; Lorusso, Marco; di Giannantonio, Massimo; Lerner, Arturo G. (2018 թ․ մարտի 16). «Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives». Brain Sciences. 8 (3): 47. doi:10.3390/brainsci8030047. ISSN 2076-3425. PMC 5870365. PMID 29547576.
Ryan TJ, Holyoak R, Vlok R, Melhuish T, Hodge A, Binks M, Hurtado G, White L (February 2019). «Intra-articular Alpha-2 Agonists as an Adjunct to Local Anesthetic in Knee Arthroscopy: A Systematic Review and Meta-Analysis». J Knee Surg. 32 (2): 138–145. doi:10.1055/s-0038-1636909. PMID 29534270. S2CID 3861878.

drugs.com

«Clonidine Monograph for Professionals». Drugs.com (անգլերեն). American Society of Health-System Pharmacists. Վերցված է 2019 թ․ փետրվարի 2-ին.
«Clonidine». Drugs.com.

medscape.org

«Treatment and Management of RLS». www.medscape.org. WebMD LLC. Վերցված է 2018 թ․ հոկտեմբերի 3-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Neil, MJ (November 2011). «Clonidine: clinical pharmacology and therapeutic use in pain management». Current Clinical Pharmacology. 6 (4): 280–7. doi:10.2174/157488411798375886. PMID 21827389. S2CID 40756251.
Viera AJ (June 2018). «Hypertension Update: Resistant Hypertension». FP Essent. 469: 20–25. PMID 29863319.
Connor DF, Fletcher KE, Swanson JM (December 1999). «A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder». J Am Acad Child Adolesc Psychiatry. 38 (12): 1551–9. doi:10.1097/00004583-199912000-00017. PMID 10596256.
Palumbo, DR; Sallee, FR; Pelham WE, Jr; Bukstein, OG; Daviss, WB; McDermott, MP (February 2008). «Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes». Journal of the American Academy of Child and Adolescent Psychiatry. 47 (2): 180–8. doi:10.1097/chi.0b013e31815d9af7. PMID 18182963.
Daviss, WB; Patel, NC; Robb, AS; McDermott, MP; Bukstein, OG; Pelham WE, Jr; Palumbo, D; Harris, P; Sallee, FR (February 2008). «Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis». Journal of the American Academy of Child and Adolescent Psychiatry. 47 (2): 189–98. doi:10.1097/chi.0b013e31815d9ae4. PMID 18182964.
Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC (April 2013). «Impact of FDA Advisories on Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder». Psychiatric Services. 64 (4): 339–46. doi:10.1176/appi.ps.201200147. PMC 4023684. PMID 23318985.
PALUMBO, DONNA R.; SALLEE, FLOYD R.; PELHAM, WILLIAM E.; BUKSTEIN, OSCAR G.; DAVISS, W. BURLESON; McDERMOTT, MICHAEL P. (February 2008). «Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes». Journal of the American Academy of Child & Adolescent Psychiatry. 47 (2): 180–188. doi:10.1097/chi.0b013e31815d9af7. PMID 18182963.
Kollins, Scott H.; Jain, Rakesh; Brams, Matthew; Segal, Scott; Findling, Robert L.; Wigal, Sharon B.; Khayrallah, Moise (2011 թ․ հունիսի 1). «Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD». Pediatrics (անգլերեն). 127 (6): e1406–e1413. doi:10.1542/peds.2010-1260. ISSN 0031-4005. PMC 3387872. PMID 21555501.
Jäkälä, P.; Riekkinen, M.; Sirviö, J.; Koivisto, E.; Kejonen, K.; Vanhanen, M.; Riekkinen Jr, P. (1999). «Guanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans». Neuropsychopharmacology. 20 (5): 460–470. doi:10.1016/S0893-133X(98)00127-4. PMID 10192826.
Nguyen M, Tharani S, Rahmani M, Shapiro M (March 2014). «A review of the use of clonidine as a sleep aid in the child and adolescent population». Clin Pediatr (Phila). 53 (3): 211–6. doi:10.1177/0009922813502123. PMID 24027233. S2CID 742140.
Hoban TF (March 2004). «Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder». Expert Rev Neurother. 4 (2): 307–16. doi:10.1586/14737175.4.2.307. PMID 15853572. S2CID 35000868.
Wilens TE, Biederman J, Spencer T (1994). «Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder». J Am Acad Child Adolesc Psychiatry. 33 (3): 424–6. doi:10.1097/00004583-199403000-00018. PMID 8169189.
Fitzgerald, PJ (October 2013). «Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine». Substance Abuse. 7: 171–83. doi:10.4137/SART.S13019. PMC 3798293. PMID 24151426.
Gourlay, SG; Stead, LF; Benowitz, NL (2004). «Clonidine for smoking cessation». The Cochrane Database of Systematic Reviews (3). CD000058. doi:10.1002/14651858.CD000058.pub2. PMC 7038651. PMID 15266422.
Streetz VN, Gildon BL, Thompson DF (April 2016). «Role of Clonidine in Neonatal Abstinence Syndrome: A Systematic Review». Ann Pharmacother. 50 (4): 301–10. doi:10.1177/1060028015626438. PMID 26783353. S2CID 40652097.
Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, Campbell-Yeo M (January 2019). «Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis». JAMA Pediatr. 173 (3): 234–243. doi:10.1001/jamapediatrics.2018.5044. PMC 6439896. PMID 30667476.
Kukoyi A, Coker S, Lewis L, Nierenberg D (January 2013). «Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature». Human & Experimental Toxicology. 32 (1): 107–110. doi:10.1177/0960327112454896. PMID 23111887. S2CID 31570614.
Chang, Eric; Ghosh, Nilasha; Yanni, Daniel; Lee, Sujin; Alexandru, Daniela; Mozaffar, Tahseen (2013). «A Review of Spasticity Treatments: Pharmacological and Interventional Approaches». Critical Reviews in Physical and Rehabilitation Medicine. 25 (1–2): 11–22. doi:10.1615/CritRevPhysRehabilMed.2013007945. ISSN 0896-2960. PMC 4349402. PMID 25750484.
van der Kolk, BA (September–October 1987). «The drug treatment of post-traumatic stress disorder». Journal of Affective Disorders. 13 (2): 203–13. doi:10.1016/0165-0327(87)90024-3. PMID 2960712.
Sutherland, SM; Davidson, JR (June 1994). «Pharmacotherapy for post-traumatic stress disorder». The Psychiatric Clinics of North America. 17 (2): 409–23. doi:10.1016/S0193-953X(18)30122-9. PMID 7937367.
Southwick, SM; Bremner, JD; Rasmusson, A; Morgan CA, 3rd; Arnsten, A; Charney, DS (November 1999). «Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder». Biological Psychiatry. 46 (9): 1192–204. doi:10.1016/S0006-3223(99)00219-X. PMID 10560025. S2CID 32148292.{{cite journal}}: CS1 սպաս․ թվային անուններ: authors list (link)
Strawn, JR; Geracioti, TD, Jr (2008). «Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder». Depression and Anxiety. 25 (3): 260–71. doi:10.1002/da.20292. PMID 17354267. S2CID 33940152.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
Boehnlein, JK; Kinzie, JD (March 2007). «Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin». Journal of Psychiatric Practice. 13 (2): 72–8. doi:10.1097/01.pra.0000265763.79753.c1. PMID 17414682. S2CID 1607064.
Huffman, JC; Stern, TA (2007). «Neuropsychiatric consequences of cardiovascular medications». Dialogues in Clinical Neuroscience. 9 (1): 29–45. doi:10.31887/DCNS.2007.9.1/jchuffman. PMC 3181843. PMID 17506224.
Najjar, F; Weller, RA; Weisbrot, J; Weller, EB (April 2008). «Post-traumatic stress disorder and its treatment in children and adolescents». Current Psychiatry Reports. 10 (2): 104–8. doi:10.1007/s11920-008-0019-0. PMID 18474199. S2CID 23494905.
Ziegenhorn, AA; Roepke, S; Schommer, NC; Merkl, A; Danker-Hopfe, H; Perschel, FH; Heuser, I; Anghelescu, IG; Lammers, CH (April 2009). «Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial». Journal of Clinical Psychopharmacology. 29 (2): 170–3. doi:10.1097/JCP.0b013e31819a4bae. PMID 19512980. S2CID 31292297.
Fazi, L; Jantzen, EC; Rose, JB; Kurth, CD; Watcha, MF (2001). «A comparison of oral clonidine and oral midazolam as preanesthetic medications in the pediatric tonsillectomy patient» (PDF). Anesthesia and Analgesia. 92 (1): 56–61. doi:10.1097/00000539-200101000-00011. PMID 11133600. S2CID 18885497.
Blount, BW; Pelletier, AL (2002). «Rosacea: A Common, Yet Commonly Overlooked, Condition». American Family Physician. 66 (3): 435–441. PMID 12182520.
Campbell, CM; Kipnes, MS; Stouch, BC; Brady, KL; Kelly, M; Schmidt, WK; Petersen, KL; Rowbotham, MC; Campbell, JN (September 2012). «Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy». Pain. 153 (9): 1815–1823. doi:10.1016/j.pain.2012.04.014. PMC 3413770. PMID 22683276.
Fragkos, Konstantinos C.; Zárate-Lopez, Natalia; Frangos, Christos C. (2016 թ․ հունվարի 25). «What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans». Therapeutic Advances in Gastroenterology (անգլերեն). 9 (3). 1756283X15625586. doi:10.1177/1756283X15625586. ISSN 1756-283X. PMC 4830099. PMID 27134659.
Egolf, A; Coffey, BJ (February 2014). «Current pharmacotherapeutic approaches for the treatment of Tourette syndrome». Drugs of Today. 50 (2): 159–79. doi:10.1358/dot.2014.50.2.2097801. PMID 24619591.
Martinotti, Giovanni; Santacroce, Rita; Pettorruso, Mauro; Montemitro, Chiara; Spano, Maria Chiara; Lorusso, Marco; di Giannantonio, Massimo; Lerner, Arturo G. (2018 թ․ մարտի 16). «Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives». Brain Sciences. 8 (3): 47. doi:10.3390/brainsci8030047. ISSN 2076-3425. PMC 5870365. PMID 29547576.
Ryan TJ, Holyoak R, Vlok R, Melhuish T, Hodge A, Binks M, Hurtado G, White L (February 2019). «Intra-articular Alpha-2 Agonists as an Adjunct to Local Anesthetic in Knee Arthroscopy: A Systematic Review and Meta-Analysis». J Knee Surg. 32 (2): 138–145. doi:10.1055/s-0038-1636909. PMID 29534270. S2CID 3861878.
Adrenoswitch: https://pubmed.ncbi.nlm.nih.gov/33103317/

ncbi.nlm.nih.gov

Kornfield R, Watson S, Higashi AS, Conti RM, Dusetzina SB, Garfield CF, Dorsey ER, Huskamp HA, Alexander GC (April 2013). «Impact of FDA Advisories on Pharmacologic Treatment of Attention Deficit Hyperactivity Disorder». Psychiatric Services. 64 (4): 339–46. doi:10.1176/appi.ps.201200147. PMC 4023684. PMID 23318985.
Kollins, Scott H.; Jain, Rakesh; Brams, Matthew; Segal, Scott; Findling, Robert L.; Wigal, Sharon B.; Khayrallah, Moise (2011 թ․ հունիսի 1). «Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD». Pediatrics (անգլերեն). 127 (6): e1406–e1413. doi:10.1542/peds.2010-1260. ISSN 0031-4005. PMC 3387872. PMID 21555501.
Fitzgerald, PJ (October 2013). «Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine». Substance Abuse. 7: 171–83. doi:10.4137/SART.S13019. PMC 3798293. PMID 24151426.
Gourlay, SG; Stead, LF; Benowitz, NL (2004). «Clonidine for smoking cessation». The Cochrane Database of Systematic Reviews (3). CD000058. doi:10.1002/14651858.CD000058.pub2. PMC 7038651. PMID 15266422.
Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, Campbell-Yeo M (January 2019). «Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis». JAMA Pediatr. 173 (3): 234–243. doi:10.1001/jamapediatrics.2018.5044. PMC 6439896. PMID 30667476.
Chang, Eric; Ghosh, Nilasha; Yanni, Daniel; Lee, Sujin; Alexandru, Daniela; Mozaffar, Tahseen (2013). «A Review of Spasticity Treatments: Pharmacological and Interventional Approaches». Critical Reviews in Physical and Rehabilitation Medicine. 25 (1–2): 11–22. doi:10.1615/CritRevPhysRehabilMed.2013007945. ISSN 0896-2960. PMC 4349402. PMID 25750484.
Huffman, JC; Stern, TA (2007). «Neuropsychiatric consequences of cardiovascular medications». Dialogues in Clinical Neuroscience. 9 (1): 29–45. doi:10.31887/DCNS.2007.9.1/jchuffman. PMC 3181843. PMID 17506224.
Campbell, CM; Kipnes, MS; Stouch, BC; Brady, KL; Kelly, M; Schmidt, WK; Petersen, KL; Rowbotham, MC; Campbell, JN (September 2012). «Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy». Pain. 153 (9): 1815–1823. doi:10.1016/j.pain.2012.04.014. PMC 3413770. PMID 22683276.
Fragkos, Konstantinos C.; Zárate-Lopez, Natalia; Frangos, Christos C. (2016 թ․ հունվարի 25). «What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans». Therapeutic Advances in Gastroenterology (անգլերեն). 9 (3). 1756283X15625586. doi:10.1177/1756283X15625586. ISSN 1756-283X. PMC 4830099. PMID 27134659.
Martinotti, Giovanni; Santacroce, Rita; Pettorruso, Mauro; Montemitro, Chiara; Spano, Maria Chiara; Lorusso, Marco; di Giannantonio, Massimo; Lerner, Arturo G. (2018 թ․ մարտի 16). «Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives». Brain Sciences. 8 (3): 47. doi:10.3390/brainsci8030047. ISSN 2076-3425. PMC 5870365. PMID 29547576.

pubchem.ncbi.nlm.nih.gov

clonidine

dailymed.nlm.nih.gov

«CATAPRES- clonidine hydrochloride tablet». DailyMed. 2016 թ․ սեպտեմբերի 6. Վերցված է 2019 թ․ դեկտեմբերի 21-ին. «Slowing of the pulse rate has been observed in most patients given clonidine, but the drug does not alter normal hemodynamic response to exercise. Other studies in patients have provided evidence of a reduction in plasma renin activity and in the excretion of aldosterone and catecholamines.»

semanticscholar.org

api.semanticscholar.org

Neil, MJ (November 2011). «Clonidine: clinical pharmacology and therapeutic use in pain management». Current Clinical Pharmacology. 6 (4): 280–7. doi:10.2174/157488411798375886. PMID 21827389. S2CID 40756251.
Nguyen M, Tharani S, Rahmani M, Shapiro M (March 2014). «A review of the use of clonidine as a sleep aid in the child and adolescent population». Clin Pediatr (Phila). 53 (3): 211–6. doi:10.1177/0009922813502123. PMID 24027233. S2CID 742140.
Hoban TF (March 2004). «Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder». Expert Rev Neurother. 4 (2): 307–16. doi:10.1586/14737175.4.2.307. PMID 15853572. S2CID 35000868.
Giannini, AJ; Extein, I; Gold, MS; Pottash, ALC; Castellani, S (1983). «Clonidine in mania». Drug Development Research. 3 (1): 101–105. doi:10.1002/ddr.430030112. S2CID 85093127.
Streetz VN, Gildon BL, Thompson DF (April 2016). «Role of Clonidine in Neonatal Abstinence Syndrome: A Systematic Review». Ann Pharmacother. 50 (4): 301–10. doi:10.1177/1060028015626438. PMID 26783353. S2CID 40652097.
Kukoyi A, Coker S, Lewis L, Nierenberg D (January 2013). «Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature». Human & Experimental Toxicology. 32 (1): 107–110. doi:10.1177/0960327112454896. PMID 23111887. S2CID 31570614.
Southwick, SM; Bremner, JD; Rasmusson, A; Morgan CA, 3rd; Arnsten, A; Charney, DS (November 1999). «Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder». Biological Psychiatry. 46 (9): 1192–204. doi:10.1016/S0006-3223(99)00219-X. PMID 10560025. S2CID 32148292.{{cite journal}}: CS1 սպաս․ թվային անուններ: authors list (link)
Strawn, JR; Geracioti, TD, Jr (2008). «Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder». Depression and Anxiety. 25 (3): 260–71. doi:10.1002/da.20292. PMID 17354267. S2CID 33940152.{{cite journal}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
Boehnlein, JK; Kinzie, JD (March 2007). «Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin». Journal of Psychiatric Practice. 13 (2): 72–8. doi:10.1097/01.pra.0000265763.79753.c1. PMID 17414682. S2CID 1607064.
Najjar, F; Weller, RA; Weisbrot, J; Weller, EB (April 2008). «Post-traumatic stress disorder and its treatment in children and adolescents». Current Psychiatry Reports. 10 (2): 104–8. doi:10.1007/s11920-008-0019-0. PMID 18474199. S2CID 23494905.
Ziegenhorn, AA; Roepke, S; Schommer, NC; Merkl, A; Danker-Hopfe, H; Perschel, FH; Heuser, I; Anghelescu, IG; Lammers, CH (April 2009). «Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial». Journal of Clinical Psychopharmacology. 29 (2): 170–3. doi:10.1097/JCP.0b013e31819a4bae. PMID 19512980. S2CID 31292297.
Fazi, L; Jantzen, EC; Rose, JB; Kurth, CD; Watcha, MF (2001). «A comparison of oral clonidine and oral midazolam as preanesthetic medications in the pediatric tonsillectomy patient» (PDF). Anesthesia and Analgesia. 92 (1): 56–61. doi:10.1097/00000539-200101000-00011. PMID 11133600. S2CID 18885497.
Patel, SS; Dunn, CJ; Bryson, HM (1996). «Epidural clonidine: a review of its pharmacology and efficacy in the management of pain during labour and postoperative and intractable pain». CNS Drugs. 6 (6): 474–497. doi:10.2165/00023210-199606060-00007. S2CID 72544106.
Ryan TJ, Holyoak R, Vlok R, Melhuish T, Hodge A, Binks M, Hurtado G, White L (February 2019). «Intra-articular Alpha-2 Agonists as an Adjunct to Local Anesthetic in Knee Arthroscopy: A Systematic Review and Meta-Analysis». J Knee Surg. 32 (2): 138–145. doi:10.1055/s-0038-1636909. PMID 29534270. S2CID 3861878.

webmd.com

«Clonidine Oral Uses». WebMD.

worldcat.org

Kollins, Scott H.; Jain, Rakesh; Brams, Matthew; Segal, Scott; Findling, Robert L.; Wigal, Sharon B.; Khayrallah, Moise (2011 թ․ հունիսի 1). «Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD». Pediatrics (անգլերեն). 127 (6): e1406–e1413. doi:10.1542/peds.2010-1260. ISSN 0031-4005. PMC 3387872. PMID 21555501.
Chang, Eric; Ghosh, Nilasha; Yanni, Daniel; Lee, Sujin; Alexandru, Daniela; Mozaffar, Tahseen (2013). «A Review of Spasticity Treatments: Pharmacological and Interventional Approaches». Critical Reviews in Physical and Rehabilitation Medicine. 25 (1–2): 11–22. doi:10.1615/CritRevPhysRehabilMed.2013007945. ISSN 0896-2960. PMC 4349402. PMID 25750484.
Fragkos, Konstantinos C.; Zárate-Lopez, Natalia; Frangos, Christos C. (2016 թ․ հունվարի 25). «What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humans». Therapeutic Advances in Gastroenterology (անգլերեն). 9 (3). 1756283X15625586. doi:10.1177/1756283X15625586. ISSN 1756-283X. PMC 4830099. PMID 27134659.
Martinotti, Giovanni; Santacroce, Rita; Pettorruso, Mauro; Montemitro, Chiara; Spano, Maria Chiara; Lorusso, Marco; di Giannantonio, Massimo; Lerner, Arturo G. (2018 թ․ մարտի 16). «Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives». Brain Sciences. 8 (3): 47. doi:10.3390/brainsci8030047. ISSN 2076-3425. PMC 5870365. PMID 29547576.